Stocktoria
Acumen Pharmaceuticals, Inc. ABOS
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-01
Acumen Pharmaceuticals, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 2,158,661 | $5.2M |
| MILLENNIUM MANAGEMENT LLC | 659,675 | $1.6M |
| TWO SIGMA INVESTMENTS, LP | 530,812 | $1.3M |
| RENAISSANCE TECHNOLOGIES LLC | 473,946 | $1.1M |
| Point72 Asset Management, L.P. | 67,375 | $159,005 |
| CITADEL ADVISORS LLC | 12,000 | $28,320 |
Source: SEC EDGAR filings · CIK 0001576885 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.